Ticker brief
NRXP
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
20
authors 14d
4
crowd 14d
+2.6σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-28 · now +0.90 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @SuperDuperInvst | C | -0.99 | 17 | +0.71 |
| @EmmanuelInvest | C | -1.11 | 1 | +0.65 |
| @theflynews | C | · | 1 | +0.00 |
| @cfaryanoconnell | C | -1.48 | 1 | +0.85 |
Recent signals20of 20 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @SuperDuperInvst | +0.90 | Add on dips; expects $5 after breakouts and $7-$11 if FDA approval arrives. — Explicit accumulation strategy with breakout levels and conditional targets. | · | tweet ↗ |
| 2026-08-28 | @SuperDuperInvst | +0.90 | Start loading NRXP and do not miss the opportunity. — Explicit forward accumulation call, with SLS cited as a prior analogue. | · | tweet ↗ |
| 2026-08-27 | @SuperDuperInvst | -0.10 | Points to a 7,500-share after-hours bid at $3.59 as liquidity for sellers. | · | tweet ↗ |
| 2026-08-27 | @SuperDuperInvst | +0.60 | Expects NRXP to rise over time similarly to SLS as SLS approaches its high. | · | tweet ↗ |
| 2026-08-27 | @SuperDuperInvst | +0.80 | Assigns 90% FDA approval odds and expects a favorable decision to drive NRXP to $7–$11. | · | tweet ↗ |
| 2026-08-26 | @SuperDuperInvst | +0.65 | Notes steady rises and predicts NRXP will be the next mover. | · | tweet ↗ |
| 2026-08-26 | @SuperDuperInvst | +0.65 | Urges review of NRXP's large future potential at 3.40. | · | tweet ↗ |
| 2026-08-26 | @cfaryanoconnell | +0.85 | Add NRXP near $3.45 and sell before year-end between $5.75 and $9.25. — Explicit add with entry area, target range and year-end horizon. | · | tweet ↗ |
| 2026-08-26 | @SuperDuperInvst | +0.85 | Adding NRXP near 3.45 to sell before year-end between 5.75 and 9.25. — Explicit add with a time horizon and target range. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.20 | Reports that three recent picks are rising and up today. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.40 | H.C. Wainwright raised its NRXP target to $45 from $40 while maintaining Buy. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.85 | Buy and hold NRXP below $3.45. — Urges investors to buy and hold NRXP, using a prior SLS opportunity as comparison. | · | tweet ↗ |
| 2026-08-25 | @SuperDuperInvst | +0.95 | Load up on NRXP below $3.45 and hold for short, near and long term. — Explicit high-conviction buy-and-hold call tied to expected FDA approval. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.85 | Load NRXP while it remains cheap around $3.50. — Urges investors to own and load NRXP before a future upside move. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.90 | Buy and hold NRXP, adding on dips. — Explicitly urges NRXP longs to buy, hold and add on dips, comparing it with SLS. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.90 | Buy NRXP before larger investors discover it. — Urges entry in NRXP based on market size and anticipated FDA approval readiness. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.85 | Accumulate NRXP slowly below $3.50 for short-, near- and long-term horizons. — Explicitly states ongoing accumulation below $3.50 across multiple horizons. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.95 | Buy NRXP below $3.50 for a potential move to $7-$13 on FDA approval. — Explicit buy call includes entry, approval probability, timing and upside targets. | · | tweet ↗ |
| 2026-08-20 | @theflynews | +0.00 | Reports earnings from multiple psychedelic-sector companies without results detail | · | tweet ↗ |
| 2026-08-17 | @EmmanuelInvest | +0.65 | Reports favorable FDA review progress, manufacturing, funding and multiple CNS program catalysts. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.